Posted by Michael Wonder on 17 Nov 2015
CADTH calls for patient input on a new submission from Eli Lilly for Trulicity
17 November 2015 - CADTH has received notice of a pending submission from Eli LIlly for dulaglutide (Trulicity) for use by certain patients with type 2 diabetes mellitus.
For more details, go to: https://www.cadth.ca/dulaglutide
